About this content About Oliver Haill Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup ...

Thermo Fisher Scientific (TMO) continues to gain from strategic partnerships. Yet, macroeconomic issues dent growth. The company carries a Zacks Rank #3 (Hold) currently.Within the pharma and biotech end market, of late, Thermo Fisher’s biosciences and bioproduction businesses have significantly expanded their capacity to meet the global vaccine manufacturing requirements. Additionally, the pharma services business has been providing pharma and biotech customers with the services they need to develop and pr ...

Thermo Fisher Scientific Inc. (NYSE:TMO) Q4 2023 Earnings Conference Call January 31, 2024 8:30 AM ET Company Participants Rafael Tejada - VP of IR Marc N. Casper - Chairman, President, and CEO Stephen Williamson - SVP and CFO Conference Call Participants Jack Meehan - Nephron Research Daniel Arias - Stifel, Nicolaus & Company Derik De Bruin - Bank of America Douglas Schenkel - Wolfe Research Vijay Kumar - Evercore ISI Tejas Savant - Morgan Stanley Operator Good morning, ladies and gentlemen, and welcome to ...

For the quarter ended December 2023, Thermo Fisher Scientific (TMO) reported revenue of $10.89 billion, down 4.9% over the same period last year. EPS came in at $5.67, compared to $5.40 in the year-ago quarter.The reported revenue represents a surprise of +1.40% over the Zacks Consensus Estimate of $10.74 billion. With the consensus EPS estimate being $5.64, the EPS surprise was +0.53%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to ...

Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.67 per share, beating the Zacks Consensus Estimate of $5.64 per share. This compares to earnings of $5.40 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 0.53%. A quarter ago, it was expected that this maker of scientific instrument and laboratory supplies would post earnings of $5.58 per share when it actually produced earnings of $5.69, delivering a surpri ...

Wall Street analysts forecast that Thermo Fisher Scientific (TMO) will report quarterly earnings of $5.64 per share in its upcoming release, pointing to a year-over-year increase of 4.4%. It is anticipated that revenues will amount to $10.74 billion, exhibiting a decline of 6.2% compared to the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.1% to its current level. This demonstrates the covering analysts' collective reassessment of their in ...

Thermo Fisher Scientific (TMO) closed at $553.39 in the latest trading session, marking a +0.3% move from the prior day. The stock's change was more than the S&P 500's daily gain of 0.22%. On the other hand, the Dow registered a gain of 0.36%, and the technology-centric Nasdaq increased by 0.32%.The maker of scientific instrument and laboratory supplies's stock has climbed by 4.29% in the past month, exceeding the Medical sector's gain of 2.3% and the S&P 500's gain of 1.61%.Analysts and investors alike wil ...

Thermo Fisher Scientific Inc. (TMO) is likely to gain in the coming quarters, backed by a slew of impressive product introductions across the portfolio. Promising developments within the company’s growth strategy, consisting of developing high-impact, innovative new products, leveraging scale and high growth in emerging markets and delivering a unique value proposition to customers, are encouraging. Stable solvency is an added upside.However, macroeconomic headwinds and competitive pressures may pose challe ...

Thermo Fisher Scientific Inc. (TMO) is slated to release fourth-quarter 2023 results on Jan 31, 2024, before market open.Thermo Fisher’s earnings of $5.69 per share in the last reported quarter topped the Zacks Consensus Estimate by 1.9%. Its earnings surpassed estimates in three of the trailing four quarters, the average surprise being 0.62%.Let's discuss the factors that are likely to be reflected in the upcoming results.Factors at PlayLike the last quarter, Thermo Fisher’s Analytical Instruments segment ...

The most recent trading session ended with Thermo Fisher Scientific (TMO) standing at $544.32, reflecting a -0.31% shift from the previouse trading day's closing. This move lagged the S&P 500's daily gain of 0.08%. Elsewhere, the Dow saw a downswing of 0.31%, while the tech-heavy Nasdaq appreciated by 0.02%.Shares of the maker of scientific instrument and laboratory supplies witnessed a gain of 4.69% over the previous month, trailing the performance of the Medical sector with its gain of 6.57% and outperfor ...